GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins-Cerep SA (XPAR:ALECR) » Definitions » Gross-Profit-to-Asset %

Eurofins-Cerep (XPAR:ALECR) Gross-Profit-to-Asset % : 24.13% (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Eurofins-Cerep Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Eurofins-Cerep's annualized Gross Profit for the quarter that ended in Dec. 2024 was €19.59 Mil. Eurofins-Cerep's average Total Assets over the quarter that ended in Dec. 2024 was €81.18 Mil. Therefore, Eurofins-Cerep's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 24.13%.


Eurofins-Cerep Gross-Profit-to-Asset % Historical Data

The historical data trend for Eurofins-Cerep's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins-Cerep Gross-Profit-to-Asset % Chart

Eurofins-Cerep Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.83 39.37 36.12 26.89 21.38

Eurofins-Cerep Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.22 27.03 27.62 19.45 24.13

Competitive Comparison of Eurofins-Cerep's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Eurofins-Cerep's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins-Cerep's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins-Cerep's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Eurofins-Cerep's Gross-Profit-to-Asset % falls into.


;
;

Eurofins-Cerep Gross-Profit-to-Asset % Calculation

Eurofins-Cerep's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=17.454/( (79.249+84.063)/ 2 )
=17.454/81.656
=21.38 %

Eurofins-Cerep's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=19.59/( (78.287+84.063)/ 2 )
=19.59/81.175
=24.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Eurofins-Cerep Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Eurofins-Cerep's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins-Cerep Business Description

Traded in Other Exchanges
N/A
Address
Le bois l Eveque, Celle l Evescault, FRA, 86600
Eurofins-Cerep SA provides in vitro pharmacology, in vitro ADME-Tox and in vivo PK services and solutions. The company also offers cost-effective drug discovery by identifying at early stages drug candidates and eliminating them. Some solutions provided by the company are - compound management, high-throughout screening, in vitro safety profiling, lead optimization profiling, in vitro ADME profiling, and in vivo PK.

Eurofins-Cerep Headlines

No Headlines